Literature DB >> 2464016

The international collaborative study on the first international standard of birch (Betula verrucosa)-pollen extract.

F C Arntzen1, T W Wilhelmsen, H Løwenstein, B Gjesing, H J Maasch, R Strömberg, R Einarsson, A Backman, S Mäkinen-Kiljunen, A Ford.   

Abstract

A selected candidate international standard preparation of birch (Betula verrucosa)-pollen extract was studied together with other birch-pollen extracts in a multinational study involving 20 laboratories in 11 countries. The biologic activity of the extract had previously been demonstrated in quantitative skin prick testing. The study methods comprised RAST inhibition, histamine release, quantitative immunoelectrophoresis, isoelectric focusing, and other methods. The results from RAST inhibition were calculated as parallel-line assays with statistical tests for linearity and parallelism. Analysis of variance was applied to test the significance of differences between potency estimates. In all assay methods, the candidate standard could be used to assign relative potencies to other birch-pollen extracts. The candidate standard was adequately stable during 36 months of storage at or below 5 degrees C. On the basis of this study, the World Health Organization has established the preparation as the International Standard for birch-pollen extract with assigned units of 100,000 IU per ampule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464016     DOI: 10.1016/0091-6749(89)90479-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Laboratory methods for allergen extract analysis and quality control.

Authors:  T J Grier
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

2.  Isolation and characterization of two IgE-reactive proteins from Azadirachta indica pollen.

Authors:  P R Karmakar; B P Chatterjee
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

Review 3.  Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 4.  Recombinant allergens/allergen standardization.

Authors:  H Løwenstein; J N Larsen
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 5.  The History, Present and Future of Allergen Standardization in the United States and Europe.

Authors:  Julia Zimmer; Jennifer Bridgewater; Fatima Ferreira; Ronald van Ree; Ronald L Rabin; Stefan Vieths
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.